IBT
IMUX icon

International Biotechnology Trust’s Immunic IMUX Stock Holding History

International Biotechnology Trust’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,300
Closed -$2.28M – 54
2020
Q3 		$2.28M Hold
12,300
– – 0.74% 26
2020
Q2 		$1.53M Buy
+12,300
New +$1.25M 0.51% 32

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

International Biotechnology Trust's IMUX Position: Q4 2020 in Review

International Biotechnology Trust sold out of Immunic (IMUX) in Q4 2020, closing a stake of 12,300 shares — an estimated $2.28M sold.

International Biotechnology Trust first reported a position in IMUX in Q2 2020 and held it in 2 quarters. The position peaked at $2.28M in Q3 2020. 69 funds tracked by Wall St. Rank hold IMUX as of Q4 2020.

  • International Biotechnology Trust reported no remaining Immunic position as of Q4 2020 after selling out during the quarter.
  • International Biotechnology Trust sold 12,300 Immunic shares in Q4 2020, an estimated $2.28M.
  • International Biotechnology Trust first reported a position in Immunic in Q2 2020 and held it in 2 quarters.
  • International Biotechnology Trust's Immunic position peaked at $2.28M in Q3 2020.
  • 69 funds tracked by Wall St. Rank held Immunic as of Q4 2020.

Based on International Biotechnology Trust's 13F filing for Q4 2020, filed 19 Feb 2021.